Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson’s Disease Relative to Alzheimer’s Disease and Controls

Early diagnosis of neurodegenerative diseases is of paramount importance for successful treatment. Lack of sensitive and early biomarkers for diagnosis of diseases like Parkinson’s disease (PD) is a handicapping problem for all movement disorders specialists. Using serum autoimmune antibodies (AIAs)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Neurol
Autors principals: Shalash, Ali, Salama, Mohamed, Makar, Marianne, Roushdy, Tamer, Elrassas, Hanan Hany, Mohamed, Wael, El-Balkimy, Mahmoud, Abou Donia, Mohamed
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2017
Matèries:
Neuroscience
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5744443/
https://ncbi.nlm.nih.gov/pubmed/29312137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2017.00720
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars